MMedication Read More Dr. Marty Makary is out as FDA commissionerMay 12, 2026 The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that…
MMental health Read More Top FDA official seeks to hire friend pushing new antidepressants warningMarch 4, 2026 WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
MMedication Read More FDA plans bonuses to staffers who complete speedy drug reviewsFebruary 27, 2026 WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More FDA commissioner’s drug review plan sparks alarmJanuary 16, 2026 WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
HHealth care Read More Top FDA drug regulator plans to depart weeks into jobDecember 3, 2025 The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
MMedication Read More Rick Pazdur to replace George Tidmarsh at FDA drug centerNovember 14, 2025 WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to…
MMedication Read More FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’November 3, 2025 WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…
UUS Read More Pentagon will build a training facility for Qatari pilots in IdahoOctober 11, 2025 WASHINGTON (AP) — The U.S. military is moving forward with plans to build a dedicated facility in Idaho…
MMedication Read More FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitzSeptember 21, 2025 WASHINGTON – For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions…